- Home
- ANVS vs SACH Comparison
ANVS vs SACH Comparison
Compare ANVS & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ANVS | SACH |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.3M | 48.6M |
| IPO Year | 2020 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ANVS | SACH |
|---|---|---|
| Price | $4.68 | $1.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | ★ $13.50 | $2.00 |
| AVG Volume (30 Days) | ★ 3.9M | 155.8K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 19.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,906,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.11 | $0.80 |
| 52 Week High | $6.61 | $1.48 |
Technical Indicators
Market Signals| Indicator | ANVS | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 71.40 | 50.65 |
| Support Level | $4.01 | $1.00 |
| Resistance Level | $5.50 | $1.08 |
| Average True Range (ATR) | 0.66 | 0.04 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 74.93 | 75.00 |
Price Performance
Historical ComparisonAbout ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.